Post-approval studies (Phase 4)Study completedNCT03038620
What this trial is testing
Impact of Liraglutide 3.0 on Body Fat Distribution
Who this might be right for
Obesity, VisceralCardiovascular DiseasesFat Disorder
University of Texas Southwestern Medical Center 235